von Willebrand factor antigen levels are associated with burden of rare nonsynonymous variants in the VWF gene

• Published in: Blood Vol. 137; no. 23; pp. 3277 - 3283
• Main Authors: Sadler, Brooke, Christopherson, Pamela A., Haller, Gabe, Montgomery, Robert R., Di Paola, Jorge
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 10.06.2021; American Society of Hematology
• Subjects: Clinical Trials and Observations; Female; Genetic Variation; Hemorrhage - genetics; Hemorrhage - metabolism; Humans; Male; rare variants; Sanger sequencing; STATISTICS, Bioinformatics; Thrombosis and Hemostasis; von Willebrand Disease, Type 1 - genetics; von Willebrand Disease, Type 1 - metabolism; von Willebrand Factor - genetics; von Willebrand Factor - metabolism; VWD classification; rare variants; VWD classification; STATISTICS, Bioinformatics; Sanger sequencing
• DOI: 10.1182/blood.2020009999
• ISSN: 0006-4971; 1528-0020

Approximately 35% of patients with type 1 von Willebrand disease (VWD) do not have a known pathogenic variant in the von Willebrand factor (VWF) gene. We aimed to understand the impact of VWF coding variants on VWD risk and VWF antigen (VWF:Ag) levels, studying 527 patients with low VWF and VWD and 210 healthy controls. VWF sequencing was performed and VWF:Ag levels assayed. A combined annotation-dependent depletion (CADD) score >20 was used as a predicted pathogenicity measure. The number of rare nonsynonymous VWF variants significantly predicted VWF:Ag levels (P = 1.62 × 10−21). There was an association between average number of rare nonsynonymous VWF variants with VWD type 1 (P = 2.4 × 10−13) and low VWF (P = 1.6 × 10−27) compared with healthy subjects: type 1 subjects possessed on average >2 times as many rare variants as those with low VWF and 8 times as many as healthy subjects. The number of rare nonsynonymous variants significantly predicts VWF:Ag levels even after controlling for presence of a variant with a CADD score >20 or a known pathogenic variant in VWF (P = 2.7 × 10−14). The number of rare nonsynonymous variants in VWF as well as the presence of a variant with CADD >20 are both significantly associated with VWF levels. The association with rare nonsynonymous variants holds even when controlling for known pathogenic variants, suggesting that additional variants, in VWF or elsewhere, are associated with VWF:Ag levels. Patients with higher VWF:Ag levels with fewer rare nonsynonymous VWF gene variants could benefit from next-generation sequencing to find the cause of their bleeding. •The number of rare nonsynonymous VWF variants is significantly associated with VWF:Ag levels, regardless of VWD type.•VWF sequence alone will not reveal the cause of VWD in a majority of patients with higher VWF:Ag levels. [Display omitted]